These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28294182)

  • 1. Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis.
    Zhou S; Zhu Q; Li X; Chen C; Liu J; Ye Y; Ruan Y; Hei Z
    Sci Rep; 2017 Mar; 7():44692. PubMed ID: 28294182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies.
    Schlesinger S; Sonntag SR; Lieb W; Maas R
    PLoS One; 2016; 11(11):e0165811. PubMed ID: 27812151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric dimethylarginine level as biomarkers of cardiovascular or all-cause mortality in patients with chronic kidney disease: a meta-analysis.
    Zhang H; Xiang S; Dai Z; Fan Y
    Biomarkers; 2021 Nov; 26(7):579-585. PubMed ID: 34253095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.
    Meinitzer A; Kielstein JT; Pilz S; Drechsler C; Ritz E; Boehm BO; Winkelmann BR; März W
    Clin Chem; 2011 Jan; 57(1):112-21. PubMed ID: 21036946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
    Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
    Shafi T; Hostetter TH; Meyer TW; Hwang S; Hai X; Melamed ML; Banerjee T; Coresh J; Powe NR
    Am J Kidney Dis; 2017 Jul; 70(1):48-58. PubMed ID: 28089476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.
    Zoccali C; Bode-Böger S; Mallamaci F; Benedetto F; Tripepi G; Malatino L; Cataliotti A; Bellanuova I; Fermo I; Frölich J; Böger R
    Lancet; 2001 Dec 22-29; 358(9299):2113-7. PubMed ID: 11784625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma ADMA, urinary ADMA excretion, and late mortality in renal transplant recipients.
    Said MY; Bollenbach A; Minović I; van Londen M; Frenay AR; de Borst MH; van den Berg E; Kayacelebi AA; Tsikas D; van Goor H; Navis G; Bakker SJL
    Amino Acids; 2019 Jun; 51(6):913-927. PubMed ID: 30915571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric Dimethylarginine (ADMA): a promising biomarker for cardiovascular disease?
    Bouras G; Deftereos S; Tousoulis D; Giannopoulos G; Chatzis G; Tsounis D; Cleman MW; Stefanadis C
    Curr Top Med Chem; 2013; 13(2):180-200. PubMed ID: 23470077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease.
    Böger RH; Endres HG; Schwedhelm E; Darius H; Atzler D; Lüneburg N; von Stritzky B; Maas R; Thiem U; Benndorf RA; Diehm C
    J Intern Med; 2011 Mar; 269(3):349-61. PubMed ID: 21175900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease.
    Testa A; Spoto B; Tripepi G; Mallamaci F; Malatino L; Fatuzzo P; Maas R; Boeger R; Zoccali C
    J Hypertens; 2005 Oct; 23(10):1825-30. PubMed ID: 16148605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric and symmetric dimethylarginine concentration as an indicator of cardiovascular diseases in rheumatoid arthritis patients: a systematic review and meta-analysis of case-control studies.
    Zafari P; Zarifian A; Alizadeh-Navaei R; Taghadosi M; Rafiei A; Samimi Z; Niksolat F
    Clin Rheumatol; 2020 Jan; 39(1):127-134. PubMed ID: 31376089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients: Cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Zelzer S; Enko D; Pilz S; Tomaschitz A; März W; Meinitzer A
    Clin Biochem; 2017 Sep; 50(13-14):739-745. PubMed ID: 28322753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine: clinical applications in pediatric medicine.
    Tain YL; Huang LT
    J Formos Med Assoc; 2011 Feb; 110(2):70-7. PubMed ID: 21377060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.
    Tripepi G; Mattace Raso F; Sijbrands E; Seck MS; Maas R; Boger R; Witteman J; Rapisarda F; Malatino L; Mallamaci F; Zoccali C
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1714-21. PubMed ID: 21642364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric dimethylarginine predicts survival in the elderly.
    Pizzarelli F; Maas R; Dattolo P; Tripepi G; Michelassi S; D'Arrigo G; Mieth M; Bandinelli S; Ferrucci L; Zoccali C
    Age (Dordr); 2013 Dec; 35(6):2465-75. PubMed ID: 23584888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg.
    Leong T; Zylberstein D; Graham I; Lissner L; Ward D; Fogarty J; Bengtsson C; Björkelund C; Thelle D;
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):961-7. PubMed ID: 18292394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
    Siegerink B; Maas R; Vossen CY; Schwedhelm E; Koenig W; Böger R; Rothenbacher D; Brenner H; Breitling LP
    Clin Res Cardiol; 2013 Mar; 102(3):193-202. PubMed ID: 23073705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients.
    Visser M; Vermeulen MA; Richir MC; Teerlink T; Houdijk AP; Kostense PJ; Wisselink W; de Mol BA; van Leeuwen PA; Oudemans-van Straaten HM
    Br J Nutr; 2012 May; 107(10):1458-65. PubMed ID: 22129964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.